Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 7/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.57 |
| ▸ | MAPT | P10636 | 5/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.57 |
| ▸ | HPGD | P15428 | 4/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | ADORA1 | P30542 | 4/20 | 0.52 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.52 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | CTRC | Q99895 | 1/20 | 0.44 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15748682 | 0.89 | ADORA2A (0.55) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL19472233 | 0.87 | MEN1 (0.63) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL9958438 | 0.87 | MEN1 (0.63) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL16614068 | 0.87 | MEN1 (0.60) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL20251432 | 0.85 | MEN1 (0.58) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL18643833 | 0.85 | ADORA2A (0.51) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL12447715 | 0.84 | ADORA2A (0.50) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL18643991 | 0.84 | MEN1 (0.59) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL18820853 | 0.84 | MEN1 (0.59) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL18267899 | 0.84 | MEN1 (0.53) | MEN1KMT2AMAPTALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2014081147-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | 주식회사 두산 (KR) | 2014-05-30 | — | — | WO | disclosed |
| US-20130035350-A1 | Novel Quinazoline Derivatives | ZHANG QIANG (US) | 2013-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130035350-A1 | Novel Quinazoline Derivatives | ERBB2, ERBB3, EGFR | MEN1 1610/4885KMT2A 2596/4885MAPT 2472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.